{"org_id": "03130848", "org_name_cn": "北京双鹭药业股份有限公司", "org_short_name_cn": "双鹭药业", "org_name_en": "Beijing Sl Pharmaceutical Co.,Ltd.", "org_short_name_en": "SL PHARM", "main_operation_business": "基因工程及相关药物的研究开发和生产经营。", "operating_scope": "　　生产片剂、重组产品、小容量注射剂、冻干粉针剂、胶囊剂、颗粒剂、原料药（鲑降钙素、司他夫定、奥曲肽、三磷酸胞苷二钠、萘哌地尔）；生产、销售“双鹭牌红欣胶囊”保健食品；普通货运；货物进出口、技术进出口、代理进出口。", "district_encode": "110108", "org_cn_introduction": "北京双鹭药业股份有限公司主要专注于基因工程及相关药物的研究开发和生产经营,紧紧围绕疾病谱的变化布局研发和生产。主要产品包括重组人粒细胞刺激因子、重组人白介素-2、重组人白介素-11、重组人碱性成纤维细胞生长因子、替莫唑胺、三氧化二砷、来那度胺、复合辅酶、胸腺五肽、依诺肝素钠、氯雷他定分散片、替米沙坦、多西他赛、阿德福韦酯、杏灵滴丸等,涉及肿瘤、肝病、心脑血管、肾病等领域。公司入选国家火炬计划重点高新技术企业、中关村科技园海淀园首批“百家创新企业”、“北京生物医药产业跨越发展工程”(G20工程)和中关村国家自主创新示范区首批“十百千工程”重点培育企业。2010-2011连续两年被评为最具竞争力的医药上市企业前五名,近几年综合实力迅速提升并已成为国内生物制药的骨干企业。", "legal_representative": "徐明波", "general_manager": "徐明波", "secretary": "梁淑洁", "established_date": 788198400000, "reg_asset": 1027350000.0, "staff_num": 757, "telephone": "86-10-88627635", "postcode": "100143", "fax": "86-10-88795883", "email": "lsj@slpharm.com.cn;slpharm@slpharm.com.cn", "org_website": "www.slpharm.com.cn", "reg_address_cn": "北京市海淀区阜石路69号碧桐园1号楼4层", "reg_address_en": "", "office_address_cn": "北京市海淀区阜石路69号碧桐园一号楼", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1094659200000, "provincial_name": "北京市", "actual_controller": "徐明波 (22.63%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "徐明波", "executives_nums": 10, "actual_issue_vol": 19000000.0, "issue_price": 12.0, "actual_rc_net_amt": 212020099.99999997, "pe_after_issuing": 19.23, "online_success_rate_of_issue": null, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}